IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Loxo Oncology, Inc.
Symbol: LOXO
Price: Last trade $22.44
Description: Re-offer range $21.50-$22.00
Trade Date: 5/12
Shares: 1.3 million
Underwriter(s) Citi, Cowen & Co., Stifel
Rating=Subscription Needed
Company: Spire Inc.
Symbol: SR
Price: Last trade $64.69
Trade Date: 5/12
Shares: 1.85 million
Underwriter(s) Morgan Stanley
Rating=Subscription Needed
Company: Core Laboratories NV
Symbol: CLB
Price: Last trade $122.74
Description: Re-offer range $118.45-$120.90
Trade Date: 5/12
Shares: 1.3 million
Underwriter(s) Credit Suisse
Rating=Subscription Needed
Company: CyrusOne Inc.
Symbol: CONE
Price: Last trade $48.48
Description: Re-offer range $47.00-$48.00
Trade Date: 5/12
Shares: 3.1 million
Underwriter(s) Citi, Morgan Stanley
Rating=Subscription Needed